mp-tscpc cyclo-g6 system (IRIDEX Inc)
Structured Review
Mp Tscpc Cyclo G6 System, supplied by IRIDEX Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mp-tscpc/mp+tscpc+cyclo+g6/pmc09915327-74-6-8
Average 90 stars, based on 1 article reviews
Images
Related Articles
Control:Article Title: Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma. Article Snippet: Purpose: The aim of this study is to compare the outcomes of micropulse transscleral cyclophotocoagulation between primary open-angle glaucoma, pseudoexfoliation glaucoma, and other types of secondary glaucoma.. Methods: Outcomes of 96 consecutive patients with refractory, end-stage glaucoma treated with micropulse transscleral cyclophotocoagulation were retrospectively reviewed.. Follow-up examinations were performed on a regular basis until 12 months postoperatively. Article Title: Micropulse vs. continuous wave transscleral cyclophotocoagulation in neovascular glaucoma Article Snippet: MP-TSCPC was performed with an MP P3 handpiece with the Article Title: Micropulse transscleral cyclophotocoagulation in a Taiwanese population: 2-year clinical outcomes and prognostic factors. Article Snippet: Purpose To evaluate the 2-year efficacy and safety of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in Taiwanese patients with glaucoma.. Methods We included the patients who received standardized MP-TSCPC with follow-up examinations on a regular basis for 24 months.. Treatment success was defined as the attainment of a postoperative intraocular pressure (IOP) between 6 and 21 mmHg or a ≥ 20% reduction in IOP from baseline without an increase in glaucoma medications. |
